![]() Midatech Pharma Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines. | ![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date 2013 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Cardiff, GB HQ Milton, GB | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 8414% increase | Employees 39 | Employees 1091% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income (£6.4m) (FY, 2025) | Net income (£2.6m) (FY, 2018) | Net income ($437.1m) (FY, 2017) |
Operating ⚠ | |||
Patent Applications | Patent Applications 81 (Apr, 2017) | Patent Applications N/A | Patent Applications 481 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.3m | Total funding raised $ 310m |

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company